Nilotinib population pharmacokinetics and exposure-response analysis in patients with imatinib-resistant or -intolerant chronic myeloid leukemia
- Francis J. Giles
- , Ophelia Q.P. Yin
- , William M. Sallas
- , Philipp D. Le Coutre
- , Richard C. Woodman
- , Oliver G. Ottmann
- , Michele Baccarani
- , Hagop M. Kantarjian
- Novartis Institutes for Biomedical Research
- Charité – Universitätsmedizin Berlin
- Goethe University
- University of Bologna
- The University of Texas Health Science Center at Houston
Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review
81
Citations
(Scopus)